Medical Subcontracting: Machining Requirements for Implants

Medical implant machining represents one of the most demanding segments in precision engineering. Manufacturing a hip prosthesis, a dental implant, or a spinal cage goes far beyond skilled craftsmanship: every machining parameter — cutting speed, surface finish, lubrication — is directly tied to patient safety and governed by a dense body of regulations. This article outlines the technical, normative, and organizational requirements that machine shops must command to compete in this market.

Why medical machining operates under fundamentally different rules than general industry

In general industry, a dimensional non-conformance results in scrap or rework. In the field of implantable medical devices, the same non-conformance can cause failure inside a human body, with irreversible consequences. It is this shift in the scale of risk that justifies an entirely different framework.

European regulation MDR 2017/745 (Medical Device Regulation), which came into full effect in May 2021, requires medical device manufacturers to demonstrate the conformity of their processes throughout the entire product lifecycle. For machining subcontractors, this means conformity is not assessed solely on the finished part: it begins with raw material selection, is confirmed at every machining operation, and is archived in a traceable manufacturing record. The machine shop is no longer a simple executor; it is a qualified link in the chain of responsibility.

This logic of process qualification — rather than product qualification alone — is what fundamentally sets medical machining apart from general precision engineering.

Biocompatible materials: titanium, medical-grade stainless steel, and PEEK — machining challenges

Material selection determines the entire machining strategy. Three material families dominate implant manufacturing, each presenting its own specific challenges.

Grade 5 titanium (Ti-6Al-4V): high performance, accelerated tool wear

Grade 5 titanium (Ti-6Al-4V) is the reference material for orthopedic implants and reconstructive surgery components. Its high mechanical strength combined with excellent biocompatibility makes it a natural choice. In machining, however, it presents severe constraints: low thermal conductivity, a tendency to adhere to cutting edges, and work hardening. These phenomena accelerate tool wear and require moderate cutting speeds, solid carbide tools with appropriate coatings (TiAlN, AlCrN), and generous lubrication — ideally through high-pressure coolant or through-tool delivery. Any localized overheating risks altering the subsurface microstructure and compromising the implant's fatigue performance.

316L stainless steel: passivation and contamination risk

316L stainless steel (austenitic, low-carbon) is widely used for surgical instruments and certain temporary implants. It machines more readily than titanium, but remains prone to work hardening and persistent burr formation. The critical post-machining step is passivation: a chemical treatment — typically using nitric or citric acid — that restores the protective oxide layer responsible for corrosion resistance and biocompatibility. This treatment must be documented and validated, as any omission or incorrect parameters directly compromise the implant's long-term performance in a biological environment.

Medical-grade PEEK: heat sensitivity and cross-contamination risk

Medical-grade PEEK (polyether ether ketone) is gaining ground for intervertebral cages and cranial implants, notably for its radiolucency and its elastic modulus close to that of cortical bone. In machining, it is heat-sensitive: excessive temperature generates degraded zones that alter the mechanical and chemical surface properties. Dry machining or compressed air cooling is often preferred to prevent any absorption of cutting fluid. Cross-contamination is also a critical concern: PEEK dust must not contaminate batches of metal parts, requiring strict workshop organization and, in some cases, dedicated machining areas.

Dimensional tolerances and surface finish: critical thresholds for implants

The chosen material dictates its own acceptable roughness ranges and tolerance classes. This is the second logical dependency: dimensional requirements are not set arbitrarily — they are derived from biological and mechanical constraints.

For articulating surfaces (femoral heads, tibial plateaus), surface roughness is typically required at Ra ≤ 0.05 µm, or below, to limit wear of the friction pair and the release of debris into the joint. For bone ingrowth surfaces (anchoring faces of cementless implants), a controlled roughness in the Ra 1 to 4 µm range is instead targeted to promote osseointegration. These two opposing requirements can coexist on a single component, requiring differentiated finishing operations by zone.

Dimensionally, tolerances frequently fall within ISO IT5 to IT7 grades, with functional fits calculated to the hundredth of a millimeter. Tapered assemblies (Morse taper or modular-type) require angular control to within a few micrometers. In this context, the thermal drift of machine tools is no longer a secondary factor: it must be continuously compensated, particularly through machining centers equipped with thermal correction systems or operating in temperature-controlled environments.

Essential standards and certifications: ISO 13485, FDA, and CE marking

Technical mastery is not enough on its own: it must be substantiated by recognized certifications. ISO 13485 is the quality management system standard specific to medical devices. It goes further than ISO 9001 by mandating a risk-based approach, enhanced control of measurement equipment, and exhaustive documentary management of quality records. For a machining subcontractor, achieving this certification means demonstrating that every step — material receiving, programming, machining, inspection, shipping — is governed by validated procedures and traceable records.

CE marking under MDR 2017/745 applies to the final device manufacturer, but the requirements it generates flow contractually to subcontractors: technical specifications, supplier audits, and process qualification. For North American markets, FDA 21 CFR Part 820 requirements (QSR / Quality System Regulation, currently converging with ISO 13485) apply under similar logic.

Full traceability and document management: from raw stock to finished implant

Material traceability is one of the most structuring requirements in this sector. Every batch of raw material must be accompanied by material certificates (EN 10204 3.1 or 3.2), and the link between that certificate and each machined part must be maintained throughout the entire process. If a non-conformance is detected after delivery — or worse, after implantation — the manufacturer must be able to precisely identify the affected batches to initiate a targeted recall.

The manufacturing record associated with each implant reference includes: the reference drawing at its current revision level, the validated CNC program, setup sheets, dimensional and roughness inspection records, surface treatment or passivation certificates, and metrology reports. This record is generally retained for at least ten years after the device is placed on the market — a period that may extend to fifteen years for high-risk implants.

Industrial clusters with deep roots in precision engineering — such as Cluses, Besançon, or Oyonnax — have developed a documentary culture and tooling expertise well suited to these requirements, which explains their strong presence in the French medical manufacturing sector.

Quality control and metrology: protocols specific to implantable components

Coordinate measuring machines (CMMs) are at the core of implant inspection. They verify the complex geometry of functional surfaces — spheres, cones, medical threads — with measurement uncertainties in the micrometer range. For curved surfaces (acetabular cups, prosthetic heads), non-contact measurement systems using interferometry or industrial computed tomography complement the inspection process.

Sampling plans cannot always rely on 100% inspection: statistics come into play through AQL (Acceptable Quality Level) plans calibrated to the criticality of the part. However, for class III implantable devices (highest risk level under MDR), exhaustive inspection is often required or strongly recommended.

Machining process qualification follows an IQ/OQ/PQ approach (Installation Qualification / Operational Qualification / Performance Qualification): the equipment is first qualified, then its operating parameters, then the repeatability of results across reference production runs. This methodology, borrowed from the pharmaceutical world, is increasingly expected by medical customers and notified bodies.

Challenges of small-batch production and implant customization

The vast majority of implants are produced in small to medium batches, or even as single units for patient-specific implants. This context imposes specific organizational constraints: frequent changeovers, modular fixturing, rigorous management of CNC programs by documented revision, and cleaning and decontamination procedures between batches to prevent cross-contamination.

The rise of customization, driven by the integration of 3D medical imaging and CAM (computer-aided manufacturing), opens new possibilities. A cranial or mandibular implant can now be machined directly from an STL file derived from a patient scan, within a matter of hours. This requires a fully controlled digital chain, from file receipt through to metrological validation of the finished part, with traceability adapted to unit production.

Shops specializing in this high-value-added production invest in 5-axis machining centers capable of cutting complex geometries in a single setup, reducing cumulative dimensional errors and the risks associated with multiple re-fixturings. Competitiveness clusters around Lyon, Annecy, and Saint-Étienne often bring together these players within shared innovation programs involving hospitals and device manufacturers.